Dovitinib-RIBOTAC
Dovitinib RIBOTAC is an RNA-targeting RIBOTAC degrader that can specifically bind to and degrade pre-miR-21. Dovitinib RIBOTAC can inhibit the metastasis of breast cancer and has anti-tumor activity[1].
Product Specifications
CAS Number
2759351-68-1
UNSPSC
12352005
Target
DNA/RNA Synthesis; PPAR; Programmed Cell Death 4 (PDCD4) ; PROTACs
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; PROTAC; Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dovitinib-ribotac.html
Purity
99.31
Solubility
DMSO : 130 mg/mL (ultrasonic)
Smiles
O=C1C(C2=NC3=CC(N4CCN(CCNC(NCCOCCOCCOCCOC5=C(O)C=C(/C=C6C(C(C(OCC)=O)=C(NC7=CC=CC=C7)S/6)=O)C=C5)=O)CC4)=CC=C3N2)=C(N)C8=C(C=CC=C8F)N1
Molecular Formula
C51H56FN9O10S
Molecular Weight
1006.11
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ACTH (Adrenocorticotrophic Hormone) (AH26), CF488A conjugate, 0.1mg/mL
Major Vault Protein (MVP) (1032), CF647 conjugate, 0.1mg/mL
CD44 Standard (DF1485), CF405S conjugate, 0.1mg/mL
CD44 Standard (156-3C11), CF640R conjugate, 0.1mg/mL
CD81 / TAPA-1 (1.3.3.22), CF405M conjugate, 0.1mg/mL
